Alcon ยท 12 hours ago
Quality Control Analyst I (2nd Shift, Sun-Thurs)
Alcon is a global leader in eye care dedicated to helping people see brilliantly. They are seeking a Quality Control Analyst I to support the Fort Worth ASPEX Team, responsible for conducting chemical analyses, maintaining lab equipment, and ensuring compliance with regulatory requirements in the Quality Control Lab Chemistry.
Health CareManufacturingMedical Device
Responsibilities
Responsible for conducting chemical analyses and maintaining lab equipment while ensuring compliance with SOP and regulatory requirements
Apply technical knowledge to perform tasks and support project goals in the Quality Control Lab Chemistry
Conduct qualitative and quantitative chemical analyses
Maintain lab equipment and ensure compliance with SOP and regulatory requirements
Ensure a safe workplace and adherence to current Good Manufacturing Practices (cGxP) and SOPs
Manage chemistry lab services
Follow procedures with decision-making authority, requiring job-related training
Support lab operations and collaborate with cross-functional teams, including production, engineering, and quality assurance
Integrate lab results into the manufacturing process, driving problem-solving and innovation through scientific principles
Adhere to Good Manufacturing Practices (GxP) regulations by strictly following SOPs, maintaining accurate and complete documentation, and ensuring rigorous quality control
Complete all required training and meet individual job requirements
Contribute to the overall compliance of the organization
Commit to continuous improvement in operations
Qualification
Required
Bachelor's Degree or Equivalent years of directly related experience (or high school +8 yrs; Assoc.+4 yrs)
The ability to fluently read, write, understand and communicate in English
Benefits
Health
Life
Retirement
Flexible time off
Much more
Company
Alcon
Alcon specializes in developing and manufacturing innovative medicines and devices to serve the cycle of eye care.
Funding
Current Stage
Public CompanyTotal Funding
unknown2010-12-15Acquired
2002-03-21IPO
Recent News
Business Wire
2026-01-07
Company data provided by crunchbase